<DOC>
	<DOCNO>NCT01400776</DOCNO>
	<brief_summary>Study WC3011 effective safe treatment postmenopausal vaginal dryness due vulvovaginal atrophy .</brief_summary>
	<brief_title>Safety &amp; Efficacy WC3011 Treatment Vulvovaginal Atrophy Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<criteria>Postmenopausal females ≥35 year either ovary remove naturally menopausal moderate severe vaginal dryness Hypersensitivity estrogen and/or progestin therapy Known suspect premalignant malignant disease ( except successfully treat skin cancer ) Manifestation treatment significant cardiovascular disease , Congestive heart failure , stroke ischemic attack Insulindependent diabetes mellitus Increased frequency severity headaches hormone estrogen therapy Drug alcohol addiction within last 2 year Participation clinical trial within 30 day Smoking ≥ 15 cigarette daily Uncontrolled hypertension systolic blood pressure ( BP ) ≥ 160 mmHg diastolic ≥ 95 mmHg</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Postmenopausal Women , Vaginal Dryness</keyword>
</DOC>